. Author manuscript; available in PMC: 2018 Jan 1.

Published in final edited form as: Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 Jan;2(1):53–65. doi: 10.1016/j.bpsc.2016.06.007

Table 1.

Demographic and clinical characteristics of study participants

	22q11DS- ASD+ Participants (n=29)	22q11DS-ASD− Participants (n=32)	Typically Developing Controls (n=55)
Age (years, +/− SD) [Age range, years]	14.34 (5.70) [6–26]	13.78 (5.35) [6–25]	12.87 (4.93) [6–26]	p=.45
Participant Education (years,+/− SD)	6.72 (4.41)	6.47 (4.72)	7.15 (5.16)	p=.81
Gender (N, % female)	11 (38%)	18 (56%)	26 (47%)	p=.36
Mean WASI IQ (+/− SD)	76.7 (11.8)	81.5 (14.0)	110.2 (20.4)	p= 9.0121e- 15^a

22q-ASD+ and 22q11DS-ASD− did not significantly differ on measures of WASI IQ (t=1.5, p=.2).